Insmed Incorporated Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals, Inc. |
$33.54 | $2.70 B | -7.55 | 486 | $36.50 M |
AKRO
Akero Therapeutics, Inc. |
$27.64 | $1.59 B | -7.1 | 63 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
FENC
Fennec Pharmaceuticals Inc. |
$6.08 | $187.43 M | 171.5 | 29 | $21.25 M |
HALO
Halozyme Therapeutics, Inc. |
$50.51 | $6.47 B | 21.1 | 350 | $1.02 B |
HRMY
Harmony Biosciences Holdings, Inc. |
$34.50 | $1.73 B | 13.15 | 268 | $714.73 M |
JANX
Janux Therapeutics, Inc. |
$53.49 | $2.29 B | -36.8 | 81 | $10.59 M |
KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$42.66 | $3.44 B | -5.21 | 1294 | $560.23 M |
RNA
Avidity Biosciences, Inc. |
$31.42 | $2.54 B | -8.99 | 391 | $10.90 M |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
SWTX
SpringWorks Therapeutics, Inc. |
$38.86 | $2.98 B | -7.81 | 368 | $191.59 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
